Coronavirus Live Updates: September accounted for 41.53% of total COVID-19 cases in India. (File)
New Delhi:
The number of COVID-19 cases in India rose to 63,12,585 as 86,821 new coronavirus cases were recorded on Thursday, according to data from the Ministry of Health. The country now has 9,40,705 active cases, 52.7 lakh recoveries and a total of 98,678 have died from the disease.
September accounted for 41.53% of the country’s total COVID-19 cases, with 26.21,418 infections out of the more than 63 lakh cases reported in the month alone. Last month, 33,390 deaths from the disease were also recorded, or about 33.84% of the 98,678 deaths recorded to date.
According to data from the Ministry of Health, the average Covid test in India has been increased to perform more than 15 lakh tests per day, and has exceeded the 140 / day / million tests recommended by the World Health Organization by more of 5 times.
Here are the live updates on the coronavirus pandemic:
Nearly 20,000 employees have obtained COVID-19: Amazon
Amazon said just over 19,800 of its employees have tested positive for Covid-19 since the start of March.
Data on the e-commerce giant’s 1.37 million frontline workers, including those at its Whole Foods Market grocery stores in the United States, showed a lower-than-expected infection rate, Amazon said.
Amazon has increased its testing to 50,000 per day at 650 sites, according to the Seattle-based company.
Russian virus second vaccine passes initial tests: report
The first clinical trials of a second Russian coronavirus vaccine have proved successful, its developer said Thursday after Russia boasted of approving the world‘s first vaccine. Russia’s Vektor – a top-secret state virology research center in Siberia – said preliminary trials were successful for its own experimental vaccine, named EpiVacCorona.
“The first two phases of clinical trials have demonstrated the efficacy and safety of the EpiVacCorona vaccine,” Vektor’s press service told Interfax news agency.
Leading health organization, biopharmaceutical company develops “Antisera” as a potential treatment for COVID-19
The Indian Council for Medical Research (ICMR), together with a Hyderabad-based biopharmaceutical company, has developed ‘highly purified antisera’ prepared by injecting inactivated SARS-CoV2 into horses, which may be a potential treatment for the COVID-19.
“ICMR and Biological E Limited, Hyderabad, have developed highly purified (raised in animals) antisera for the prophylaxis and treatment of COVID-19,” the leading health research organization said.
Antisera are blood serum rich in antibodies against specific antigens and are injected into humans to help jump-start the immune system to fight specific infections.
